![Validity and Reliability of Neurological Scores in Mice Exposed to Middle Cerebral Artery Occlusion | Stroke Validity and Reliability of Neurological Scores in Mice Exposed to Middle Cerebral Artery Occlusion | Stroke](https://www.ahajournals.org/cms/asset/f459aaa6-5d8d-4594-b22b-7b2ede41a797/2875ga1.jpg)
Validity and Reliability of Neurological Scores in Mice Exposed to Middle Cerebral Artery Occlusion | Stroke
![Neurological involvement common in kids and teens with acute COVID-19 and MIS-C - Boston Children's Answers Neurological involvement common in kids and teens with acute COVID-19 and MIS-C - Boston Children's Answers](https://fcgj83z0eul3uqz2k1ej79r8-wpengine.netdna-ssl.com/wp-content/uploads/2021/03/covid_misc_2x_blog-1024x682.jpg)
Neurological involvement common in kids and teens with acute COVID-19 and MIS-C - Boston Children's Answers
![Cerebral performance categories (CPC) at hospital discharge overall... | Download Scientific Diagram Cerebral performance categories (CPC) at hospital discharge overall... | Download Scientific Diagram](https://www.researchgate.net/profile/Tetsuya-Matoba/publication/332181122/figure/fig2/AS:743653228179459@1554312154791/Cerebral-performance-categories-CPC-at-hospital-discharge-overall-according-to.png)
Cerebral performance categories (CPC) at hospital discharge overall... | Download Scientific Diagram
![Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 - The Lancet Neurology Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d61c99f8-a767-4539-a254-4bd5d3b351d2/gr1.jpg)
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 - The Lancet Neurology
![Rapid neurological deterioration in a patient with multiple sclerosis treated with systemic interleukin-2 and interferon-alpha 2b for metastatic renal cell carcinoma. | Journal of Neurology, Neurosurgery & Psychiatry Rapid neurological deterioration in a patient with multiple sclerosis treated with systemic interleukin-2 and interferon-alpha 2b for metastatic renal cell carcinoma. | Journal of Neurology, Neurosurgery & Psychiatry](https://jnnp.bmj.com/content/62/1/100.1.extract.jpg)